← Eichor
Condition: Metastatic Lobular Breast Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Metastatic Lobular Breast Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Phase 1 · 1 location(s) · Novartis Pharmaceuticals · NCT07630961Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in
Phase N/A · 1 location(s) · Oncology Institute of Southern Switzerland · NCT04543799A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Phase N/A · 4 location(s) · University of California, San Francisco · NCT05964504[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Phase 1 · 1 location(s) · University of California, Davis · NCT07020806IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07229417Biomarkers to Detect Endocrine Therapy Resistance
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06067503
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.